Literature DB >> 19384565

Behavioral perturbations after prenatal neurogenesis disturbance in female rat.

Franck Hazane1, Marie-Odile Krebs, Thérèse M Jay, Gwenaëlle Le Pen.   

Abstract

The exposure to methylazoxymethanol (MAM) at embryonic day 17 (E17) results in behavioral anomalies in male rats that mimic several features of schizophrenia, including their emergence after puberty. Given that both men and women are likely to develop this illness and that currently no animal model is validated for females, we examined the behavioral consequences of E17 MAM exposure in female rats. We compared E17 MAM- and saline-exposed female rats before and/or after puberty for spontaneous activity, alternance and spatial recognition (Y-maze), spatial learning (Morris water maze), and sensory gating using the prepulse inhibition task. MAM-exposed female rats exhibited a significant increase in spontaneous locomotor activity in a novel environment, compared to sham animals, which emerged only after puberty. They also had deficits in spontaneous alternation performance and spatial recognition in a Y-maze as well as reference memory deficits in a Morris water maze task. Lastly, MAM-exposed female rats spent significantly less time in social interaction at both pre- and post-puberty and had a deficit in prepulse inhibition of the startle reflex (PPI) at adulthood. In conclusion, the present results show that, in female rat, exposure to MAM at E17 results in a pattern of behavioral changes that, on the whole, mimic positive, negative, and cognitive dimensions of schizophrenia. E17 MAM exposure thus appears to be a valid model for schizophrenia in both males and females.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384565     DOI: 10.1007/s12640-009-9035-z

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  33 in total

Review 1.  The neurobiological basis of spontaneous alternation.

Authors:  Robert Lalonde
Journal:  Neurosci Biobehav Rev       Date:  2002-01       Impact factor: 8.989

2.  Opposing effects of two CCK(B) agonists on the retrieval phase of a two-trial memory task after systemic injection in the rat.

Authors:  I Léna; H Simon; B P Roques; V Daugé
Journal:  Neuropharmacology       Date:  1999-04       Impact factor: 5.250

3.  Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty.

Authors:  G V Rebec; C P Grabner; M Johnson; R C Pierce; M T Bardo
Journal:  Neuroscience       Date:  1997-02       Impact factor: 3.590

4.  Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia.

Authors:  L M Talamini; T Koch; G J Ter Horst; J Korf
Journal:  Brain Res       Date:  1998-04-13       Impact factor: 3.252

5.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

6.  Leptin decreases feeding and exploratory behaviour via interactions with CCK(1) receptors in the rat.

Authors:  M Buyse; A Bado; V Daugé
Journal:  Neuropharmacology       Date:  2001-05       Impact factor: 5.250

7.  Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.

Authors:  Robert E Featherstone; Zoe Rizos; José N Nobrega; Shitij Kapur; Paul J Fletcher
Journal:  Neuropsychopharmacology       Date:  2006-10-11       Impact factor: 7.853

Review 8.  Possible confounding influence of strain, age and gender on cognitive performance in rats.

Authors:  J S Andrews
Journal:  Brain Res Cogn Brain Res       Date:  1996-06

9.  Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes.

Authors:  F Dellu; V Fauchey; M Le Moal; H Simon
Journal:  Neurobiol Learn Mem       Date:  1997-03       Impact factor: 2.877

Review 10.  Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.

Authors:  Rajiv Tandon; Matcheri S Keshavan; Henry A Nasrallah
Journal:  Schizophr Res       Date:  2008-06-02       Impact factor: 4.939

View more
  12 in total

Review 1.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  Altered spatial learning, cortical plasticity and hippocampal anatomy in a neurodevelopmental model of schizophrenia-related endophenotypes.

Authors:  P Leon Brown; Paul D Shepard; Greg I Elmer; Sara Stockman; Rebecca McFarland; Cheryl L Mayo; Jean Lud Cadet; Irina N Krasnova; Martin Greenwald; Carrie Schoonover; Michael W Vogel
Journal:  Eur J Neurosci       Date:  2012-07-05       Impact factor: 3.386

3.  Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.

Authors:  Gen Kaneko; Basavaraju G Sanganahalli; Stephanie M Groman; Helen Wang; Daniel Coman; Jyotsna Rao; Peter Herman; Lihong Jiang; Katherine Rich; Robin A de Graaf; Jane R Taylor; Fahmeed Hyder
Journal:  Biol Psychiatry       Date:  2016-05-30       Impact factor: 13.382

4.  Gestational methylazoxymethanol exposure leads to NMDAR dysfunction in hippocampus during early development and lasting deficits in learning.

Authors:  Melissa A Snyder; Alicia E Adelman; Wen-Jun Gao
Journal:  Neuropsychopharmacology       Date:  2012-09-12       Impact factor: 7.853

5.  Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia.

Authors:  Stephanie M Perez; Li Chen; Daniel J Lodge
Journal:  Psychoneuroendocrinology       Date:  2014-05-14       Impact factor: 4.905

6.  MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs.

Authors:  Adam C Mar; Simon R O Nilsson; Begoña Gamallo-Lana; Ming Lei; Theda Dourado; Johan Alsiö; Lisa M Saksida; Timothy J Bussey; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2017-07-26       Impact factor: 4.530

7.  Hippocampal developmental vulnerability to methylmercury extends into prepubescence.

Authors:  Maryann Obiorah; Elizabeth McCandlish; Brian Buckley; Emanuel DiCicco-Bloom
Journal:  Front Neurosci       Date:  2015-05-12       Impact factor: 4.677

8.  Alterations in spatial memory and anxiety in the MAM E17 rat model of hippocampal pathology in schizophrenia.

Authors:  Francois Gastambide; Amy M Taylor; Clare Palmer; Heta Svard; Maija Karjalainen; Sanna K Janhunen; Mark Tricklebank; David M Bannerman
Journal:  Psychopharmacology (Berl)       Date:  2015-01-31       Impact factor: 4.530

Review 9.  Animal Models of Maladaptive Traits: Disorders in Sensorimotor Gating and Attentional Quantifiable Responses as Possible Endophenotypes.

Authors:  Juan P Vargas; Estrella Díaz; Manuel Portavella; Juan C López
Journal:  Front Psychol       Date:  2016-02-19

10.  Effect of estrous cycle on schizophrenia-like behaviors in MAM exposed rats.

Authors:  Stephanie M Perez; Jennifer J Donegan; Daniel J Lodge
Journal:  Behav Brain Res       Date:  2019-01-17       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.